1. Harmful Algal Bloom–Associated Illnesses in Humans and Dogs Identified Through a Pilot Surveillance System — New York, 2015
- Author
-
Lloyd R. Wilson, Scott Kishbaugh, James B. Hyde, Grant Zelin, David M. Dziewulski, Mary C. Figgatt, and Eric J. Wiegert
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Health (social science) ,Adolescent ,Epidemiology ,Harmful Algal Bloom ,Health, Toxicology and Mutagenesis ,030106 microbiology ,New York ,Poison control ,Pilot Projects ,Disease ,Algal bloom ,Aquatic organisms ,Young Adult ,03 medical and health sciences ,Dogs ,Health Information Management ,Environmental health ,Health care ,medicine ,Animals ,Humans ,Full Report ,Dog Diseases ,Child ,business.industry ,General Medicine ,Middle Aged ,030104 developmental biology ,Child, Preschool ,Population Surveillance ,Female ,business - Abstract
Cyanobacteria, also known as blue-green algae, are photosynthetic, aquatic organisms found in fresh, brackish, and marine water around the world (1). Rapid proliferation and accumulation of potentially toxin-producing cyanobacteria characterize one type of harmful algal bloom (HAB). HABs have the potential to cause illness in humans and animals (2,3); however, the epidemiology of these illnesses has not been well characterized. Statewide in 2015, a total of 139 HABs were identified in New York, 97 (70%) of which were confirmed through laboratory analysis; 77 independent beach closures were ordered at 37 beaches on 20 different bodies of water. To better characterize HAB-associated illnesses, during June-September 2015, the New York State Department of Health (NYSDOH) implemented a pilot surveillance system in 16 New York counties. Activities included the collection of data from environmental HAB reports, illness reports, poison control centers, and syndromic surveillance, and increased outreach to the public, health care providers, and veterinarians. During June-September, 51 HAB-associated illnesses were reported, including 35 that met the CDC case definitions*; 32 of the cases occurred in humans and three in dogs. In previous years, New York never had more than 10 HAB-associated illnesses reported statewide. The pilot surveillance results from 16 counties during a 4-month period suggest that HAB-associated illnesses might be more common than previously reported.
- Published
- 2017